Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Scarring”

791 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 791 results

Not applicableNot Yet RecruitingNCT06588192
What this trial is testing

Renal Survival in Patients with Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 97
Not applicableStudy completedNCT01560052
What this trial is testing

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)

Who this might be right for
IgA Glomerulonephritis
The George Institute 503
Not applicableStudy completedNCT01538433
What this trial is testing

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 603
Testing effectiveness (Phase 2)Looking for participantsNCT06740526
What this trial is testing

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Who this might be right for
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Large-scale testing (Phase 3)Study completedNCT00657059
What this trial is testing

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 151
Large-scale testing (Phase 3)Ended earlyNCT05288855
What this trial is testing

Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis

Who this might be right for
Adolescent Lupus NephritisPediatric Lupus Nephritis
Aurinia Pharmaceuticals Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Study completedNCT03804359
What this trial is testing

Personalized Medicine for Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 68
Not applicableStudy completedNCT05337124
What this trial is testing

A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 229
Large-scale testing (Phase 3)Ended earlyNCT00089804
What this trial is testing

Study of LJP 394 in Lupus Patients With History of Renal Disease

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
La Jolla Pharmaceutical Company 943
Large-scale testing (Phase 3)Study completedNCT03597464
What this trial is testing

Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 216
Testing effectiveness (Phase 2)Ended earlyNCT03448692
What this trial is testing

Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Pfizer 47
Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)Ended earlyNCT05847920
What this trial is testing

Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 53
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Post-approval studies (Phase 4)Study completedNCT00498368
What this trial is testing

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Mayo Clinic 34
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Post-approval studies (Phase 4)UnknownNCT01758120
What this trial is testing

Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 135
Load More Results